Physician

Erin M Bertino, MD

According to 2025 Medicare claims, Erin Bertino, MD (NPI: 1043355688) practices medical oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43082-7989. Bertino is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Bertino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 36,332 HCPCS/CPT codes, and received $714,584 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 748 prescription claims across 132 beneficiaries totaling $824,037 in drug costs, led by Brukinsa (Zanubrutinib). 2022 DME data shows 24 claims. Open Payments data shows 19 records totaling $14,712. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $55,464 to $714,584. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $401,738 and ending at $824,037. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,354 and ending at $1,210.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	209	605	$55,464
2016	246	696	$61,825
2017	215	667	$57,774
2018	177	600	$51,003
2019	192	602	$54,001
2020	168	536	$46,957
2021	164	469	$51,288
2022	129	279	$26,890
2023	221	13,659	$163,388
2024	244	36,332	$714,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	694	$401,738
2016	109	568	$663,739
2017	109	723	$878,177
2018	94	656	$952,804
2019	107	671	$1,297,684
2020	110	650	$1,006,189
2021	105	561	$687,152
2022	107	393	$881,615
2023	122	692	$1,039,795
2024	132	748	$824,037

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	35	$1,903
2016	N/R	15	$1,313
2017	N/R	32	$1,446
2018	N/R	75	$3,305
2019	N/R	35	$1,161
2020	N/R	41	$1,439
2021	N/R	64	$2,878
2022	N/R	24	$866
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	34	34	$154
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	42	115	$132
96413	Administration of chemotherapy into vein, 1 hour or less	35	80	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	62	103	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	191	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	12	360	$169,400
Revlimid	Lenalidomide	11	294	$166,498
Eliquis	Apixaban	34	1,020	$19,682
Anastrozole	Anastrozole	92	5,308	$1,100
Letrozole	Letrozole	49	2,665	$486

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$14,712	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Erin M. Bertino, MD?

Tedicare shows public-source Medicare data for Erin M. Bertino, MD (NPI 1043355688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin M. Bertino, MD have ACO affiliation data?

Erin M. Bertino, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Erin M. Bertino, MD?

Erin M. Bertino, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Erin M. Bertino, MD have Open Payments data?

Erin M. Bertino, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.